Univest
Univest
  • Markets
  • Drug Manufacturing Stocks Rally Up to 89% in Six Months: Laurus Labs, Gland Pharma, Divi’s Laboratories and Piramal Pharma as Nifty Pharma Hits a Record on 9 November 2026

    • November 13, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Drug Manufacturing Stocks Rally Up to 89% in Six Months: Laurus Labs, Gland Pharma, Divi's Laboratories and Piramal Pharma as Nifty Pharma Hits a Record on 9 November 2026

    Drug manufacturing stocks such as Laurus Labs, Gland Pharma and Divi’s have risen up to 89% in six months as Nifty Pharma hit a record. Data, drivers and risks.

    read more
  • 3 Telecom and Enterprise IT Services Provider, Active Ingredients and Formulations Maker and Hair Oil and Edible Oil Brand Owner Stocks With a Strong Future Roadmap: Tech Mahindra, Laurus Labs and Marico

    • November 4, 2026
    • Posted by: Chaitanya Auti
    • Category: Best Stocks
    No Comments
    3 Telecom and Enterprise IT Services Provider, Active Ingredients and Formulations Maker and Hair Oil and Edible Oil Brand Owner Stocks With a Strong Future Roadmap: Tech Mahindra, Laurus Labs and Marico

    IT Services, API and Hair Oil Stocks with a strong future roadmap: Tech Mahindra, Laurus Labs and Marico. Compare price, valuation, return on equity and revenue growth as of 3 November 2026.

    read more
  • 3 Specialty Performance Chemicals Maker, Contract Drug Maker and Active Ingredients and Formulations Company Stocks With a Strong Future Roadmap: Clean Science and Technology, Innova Captab and Laurus Labs

    • November 2, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Specialty Performance Chemicals Maker, Contract Drug Maker and Active Ingredients and Formulations Company Stocks With a Strong Future Roadmap: Clean Science and Technology, Innova Captab and Laurus Labs

    Specialty Chemical, Contract Drug and API Stocks with a strong future roadmap: Clean Science and Technology, Innova Captab and Laurus Labs. Compare price, valuation, return on equity and revenue growth as of 30 October 2026.

    read more
  • 3 Branded Generics Pharma Company, Pharma Formulations and Custom Synthesis Company and Integrated Apparel Maker Stocks With a Strong Future Roadmap: Emcure Pharmaceuticals, Laurus Labs and KPR Mill

    • October 30, 2026
    • Posted by: Lakshit Sharma
    • Category: Best Stocks
    No Comments
    3 Branded Generics Pharma Company, Pharma Formulations and Custom Synthesis Company and Integrated Apparel Maker Stocks With a Strong Future Roadmap: Emcure Pharmaceuticals, Laurus Labs and KPR Mill

    Generic, Custom Pharma and Apparel Stocks with a strong future roadmap: Emcure Pharmaceuticals, Laurus Labs and KPR Mill. Compare price, valuation, return on equity and revenue growth as of 28 October 2026.

    read more
  • Laurus Labs Share Price Jumps 5.35% to Record High of Rs 2,381.90 on 30 October 2026 as Laurus Labs Q2 Results Show Profit Up 126% and Rs 1 Laurus Labs Dividend Declared: Should You Buy?

    • October 30, 2026
    • Posted by: Kunal Singla
    • Category: Results
    No Comments
    Laurus Labs Share Price Jumps 5.35% to Record High of Rs 2,381.90 on 30 October 2026 as Laurus Labs Q2 Results Show Profit Up 126% and Rs 1 Laurus Labs Dividend Declared: Should You Buy?

    Laurus Labs share price hit a record Rs 2,381.90 on 30 October 2026 after Q2 FY27 profit rose 126% to Rs 441 crore and a Rs 1 interim dividend was declared. Targets and should you buy.

    read more
  • 3 Cardiovascular Medicines Leader, Innovation Led Generics Company and Anti Retroviral Ingredients Specialist Stocks With a Strong Future Roadmap: Torrent Pharmaceuticals, Glenmark Pharmaceuticals and Laurus Labs

    • October 29, 2026
    • Posted by: Harsh Piplani
    • Category: Best Stocks
    No Comments
    3 Cardiovascular Medicines Leader, Innovation Led Generics Company and Anti Retroviral Ingredients Specialist Stocks With a Strong Future Roadmap: Torrent Pharmaceuticals, Glenmark Pharmaceuticals and Laurus Labs

    Heart Care Medicine and API Pharma Stocks with a strong future roadmap: Torrent Pharmaceuticals, Glenmark Pharmaceuticals and Laurus Labs. Compare price, valuation, return on equity and revenue growth as of 28 October 2026.

    read more
  • 3 Branded Generics Company, Specialty Prescription Brand Owner and Active Ingredients Producer Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, Ajanta Pharma and Laurus Labs

    • October 29, 2026
    • Posted by: Chaitanya Auti
    • Category: Best Stocks
    No Comments
    3 Branded Generics Company, Specialty Prescription Brand Owner and Active Ingredients Producer Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, Ajanta Pharma and Laurus Labs

    Branded Generics, Specialty and API Pharma with a strong future roadmap: Lincoln Pharmaceuticals, Ajanta Pharma and Laurus Labs. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.

    read more
  • 3 Emerging Markets Generics Company, Global Generics Leader and Active Ingredients Producer Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Dr. Reddy’s Laboratories and Laurus Labs

    • October 28, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Emerging Markets Generics Company, Global Generics Leader and Active Ingredients Producer Stocks With a Strong Future Roadmap: Caplin Point Laboratories, Dr. Reddy's Laboratories and Laurus Labs

    Emerging Market, Global Pharma and API Stocks with a strong future roadmap: Caplin Point Laboratories, Dr. Reddy’s Laboratories and Laurus Labs. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.

    read more
  • 3 Fermentation Based Ingredients Maker, Active Ingredients and Contract Research Company and OTC Medicines Producer Stocks With a Strong Future Roadmap: Concord Biotech, Laurus Labs and Marksans Pharma

    • October 26, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Fermentation Based Ingredients Maker, Active Ingredients and Contract Research Company and OTC Medicines Producer Stocks With a Strong Future Roadmap: Concord Biotech, Laurus Labs and Marksans Pharma

    Fermentation API, Contract Pharma and OTC Stocks with a strong future roadmap: Concord Biotech, Laurus Labs and Marksans Pharma. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.

    read more
  • 3 Anti-Retroviral and Ingredients Leader, Excipients and Food Additive Maker and US Generics Exporter Stocks With a Strong Future Roadmap: Laurus Labs, Sudeep Pharma and Alembic Pharmaceuticals

    • October 26, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Anti-Retroviral and Ingredients Leader, Excipients and Food Additive Maker and US Generics Exporter Stocks With a Strong Future Roadmap: Laurus Labs, Sudeep Pharma and Alembic Pharmaceuticals

    API, Excipient and Generic Pharma Stocks with a strong future roadmap: Laurus Labs, Sudeep Pharma and Alembic Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.

    read more
  • 1
  • 2